Literature DB >> 1757080

The predictive value of histological classification into degrees of differentiation of squamous cell carcinoma of the larynx and hypopharynx compared with the survival of patients.

G Wiernik1, P R Millard, J L Haybittle.   

Abstract

In the course of running two clinical trials between 1966 and 1985, data became available for 1315 patients, 713 in the first trial and 602 patients in the second trial, which has allowed comparison between histological findings in laryngeal and hypopharyngeal carcinoma, the observed survival and the tumour-free rates for these patients who were followed for up to 10 years. Extensive histopathology reviews have revealed over 98% agreement on tumour cell type between the initial report and that of the reviewer. Highly significant differences have been found for squamous cell carcinoma between the observed survival and the tumour-free rates for patients with well-differentiated and with anaplastic lesions. There was a statistically significant greater proportion of patients with well-differentiated tumours at larynx sites and in stage 1 when compared with patients with anaplastic tumours, but even when this was taken into account, multivariate analyses showed that tumour grading still made an independent significant contribution to the prediction of prognosis. For squamous cell carcinoma only very simple and rapidly assessed histopathological features need to be identified to classify tumours into the two grades employed in this study. The analyses have confirmed the prognostic significance of tumour grading in squamous cell carcinoma in the larynx and hypopharynx.

Entities:  

Mesh:

Year:  1991        PMID: 1757080     DOI: 10.1111/j.1365-2559.1991.tb00230.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  12 in total

1.  Identification and validation of gene expression models that predict clinical outcome in patients with early-stage laryngeal cancer.

Authors:  E Fountzilas; K Markou; K Vlachtsis; A Nikolaou; P Arapantoni-Dadioti; E Ntoula; G Tassopoulos; M Bobos; P Konstantinopoulos; G Fountzilas; D Spentzos
Journal:  Ann Oncol       Date:  2012-01-04       Impact factor: 32.976

2.  Carcinosarcoma of the Larynx- A Rare Site Entity.

Authors:  Byna Syam Sundara Rao; Bhavana Grandhi; Vissa Shanthi; Nandam Mohan Rao; B Krishna Murthy
Journal:  J Clin Diagn Res       Date:  2016-05-01

3.  Value of ezrin, maspin and nm23-H1 protein expressions in predicting outcome of patients with head and neck squamous-cell carcinoma treated with radical radiotherapy.

Authors:  Paulette Mhawech-Fauceglia; Pavel Dulguerov; Amy Beck; Marta Bonet; Abdelkarim S Allal
Journal:  J Clin Pathol       Date:  2006-05-12       Impact factor: 3.411

4.  The incidence of thyroid cartilage invasion through the anterior commissure in clinically early-staged laryngeal cancer.

Authors:  Murat Ulusan; Selin Unsaler; Bora Basaran; Dilek Yılmazbayhan; Ismet Aslan
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-01-17       Impact factor: 2.503

5.  Multiple chromosomal underrepresentations detected by interphase cytogenetics - possible prognostic markers in head and neck tumors?

Authors:  B Kleist; A Bankau; G Lorenz; M Poetsch
Journal:  Pathol Oncol Res       Date:  2001       Impact factor: 3.201

6.  Clinical study of poorly differentiated head and neck squamous cell carcinoma: a prospective cohort study in China.

Authors:  Shuo Ding; Wei Guo; Gaofei Yin; Nuan Li; Hongfei Liu; Junwei Huang; Zheng Yang; Hongbo Xu; Xiaohong Chen; Yang Zhang; Zhigang Huang
Journal:  Ann Transl Med       Date:  2022-06

7.  Syndecan-1 expression has prognostic significance in head and neck carcinoma.

Authors:  A Anttonen; M Kajanti; P Heikkilä; M Jalkanen; H Joensuu
Journal:  Br J Cancer       Date:  1999-02       Impact factor: 7.640

8.  Human papillomavirus detection in head and neck squamous cell carcinoma.

Authors:  Dayahindara Vietía; Juan Liuzzi; Maira Avila; Zoraya De Guglielmo; Yrneh Prado; María Correnti
Journal:  Ecancermedicalscience       Date:  2014-10-23

9.  Association between syndecan-1 expression and clinical outcome in squamous cell carcinoma of the head and neck.

Authors:  P Inki; H Joensuu; R Grénman; P Klemi; M Jalkanen
Journal:  Br J Cancer       Date:  1994-08       Impact factor: 7.640

10.  Motility-related protein-1 (MRP-1/CD9) expression can predict disease-free survival in patients with squamous cell carcinoma of the head and neck.

Authors:  P Mhawech; P Dulguerov; E Tschanz; C Verdan; C Ares; A S Allal
Journal:  Br J Cancer       Date:  2004-01-26       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.